The role of granzyme B in murine models of acute graft-versus-host disease and graft rejection

Blood

Volumn 87, Issue 4, 1996, Pages 1232-1237

  Graubert, Timothy A ^b   Russell, John H ^b   Ley, Timothy J ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GRANZYME B; H2 ANTIGEN; SERINE PROTEINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CELL DEATH; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; IMMUNOPHENOTYPING; LYMPHOCYTE SUBPOPULATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL;

EID: 0030027957     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.4.1232.bloodjournal8741232     Document Type: Article

References (40)

1. Yannelii JR, Sullivan JA, Mandell GL, Engelhard VH: Reorientation and fusion of cytotoxic T lymphocyte granules after interaction with target cells as determined by high resolution cinematography. J Immunol 136:377, 1986
2. Lowrey DM, Aebischer T, Olsen KJ, Lichtenheif M, Rupp F, Hengartner H, Podack ER: Cloning, analysis, and expression of murine perform 1 cDNA, a component of cytolytic T-cell granules with homology to complement component C9. Proc Natl Acad Sci USA 86:247, 1989
3. Hayes MP, Berrebi GA, Henkart PA: Induction of target cell DNA release by the cytotoxic T lymphocyte granule protease granzyme A. J Exp Med 170:933, 1989
4. Shi L, Kam C-M, Powers JC, Aebersold R, Greenberg AH: Purification of three cytotoxic lymphocyte granule serine proteases that induce apoptosis through distinct substrate and target cell interactions. J Exp Med 176:1521, 1992
5. Poe M, Blake JT, Boulton DA, Gammon M, Sigal NH, Wu JK, Zweerink HJ: Human cytotoxic lymphocyte granzyme B: Its purification from granules and the characterization of substrate and inhibitor specificity. J Biol Chem 266:98, 1991
6. Heusel JW, Wesselschmidt RL, Shresta S, Russell JH, Ley TJ: Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell 76:977, 1994
7. Shresta S, MacIvor DM, Heusel JW, Russell JH, Ley TJ: Natural killer and iymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc Natl Acad Sci USA 92:5679, 1995
8. Baetz K, Isaaz S, Griffiths GM: Loss of cytotoxic T lymphocyte function in Chediak-Higashi syndrome arises from a secretory defect that prevents lytic granule exocytosis. J Immunol 154:6122, 1995
9. Roder JC, Haliotis T, Klein M, Korec S, Jett JR, Ortaldo J, Heberman RB, Katz P, Fauci AS: A new immunodeficiency disorder in humans involving NK cells. Nature 284:553, 1980
10. Roder JC, Duwe AK: The beige mutation in the mouse selectively impairs natural killer cell function. Nature 278:451, 1979
11. Korngold R, Sprent J: Surface markers of T cells causing lethal graft-versus-host disease to class I vs class II H-2 differences. J Immunol 135:3004, 1985
12. Sprent J, Schaefer M, Lo D, Korngold R: Properties of purified T cell subsets: In vivo responses to class I vs class II H-2 differences. J Exp Med 163:998, 1986
13. + cells in class I-different hosts. J Exp Med 167:556, 1988
14. Cudkowicz G, Stimpfling JH: Induction of immunity and of unresponsiveness to parental marrow grafts in adult F1 hybrid mice. Nature 204:450, 1964
15. Cudkowicz G, Bennett M: Peculiar immunobiology of bone marrow allografts. II. Rejection of parental grafts by resistance F1 hybrid mice. J Exp Med 134:1513, 1971
16. Bix M, Liao N-S, Zijlstra M, Loring J, Jaenisch R, Raulet D: Rejection of class I MHC-deficient haematopoietic cells by irradiated MHC-matched mice. Nature 349:329, 1991
17. Malnati MS, Peruzzi M, Parker KC, Biddison WE, Ciccone E, Moretta A, Long EO: Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267:1016, 1995
18. Ljunggren H-G, Karre K: In search of the "missing self": MHC molecules and NK recognition. Immunol Today 11:237, 1990
19. Murphy WJ, Kumar V, Bennett M: Rejection of bone marrow allografts by mice with severe combined immune deficiency (SCID): Evidence that natural killer cells can mediate the specificity of marrow graft rejection J Exp Med 165:1212, 1987
20. Kiessling R, Hochman PS, Haller O, Shearer GM, Wigzell H, Cudkowicz G: Evidence for a similar or common mechanism for natural killer cells and resistance to hemopoietic grafts. Eur J Immunol 7:655, 1977
21. Lotzova E, Savary CA, Pollack SB: Prevention of rejection of allogeneic bone marrow transplants by NK1.1 antiserum. Transplantation 35:490, 1983
22. Russell JH, Meleedy-Rey P, McCulley DE, Sha WC, Nelson CA, Loh DY: Evidence for CD8-independent T cell maturation in transgenic mice. J Immunol 144:3318, 1990
23. Bennett M, Rembecki RM, Sentman CL, Murphy WJ, Yu YYL, Davenport C, Kumar V: Bone marrow transplantation and natural killer (NK) cells in mice, in Rolstad B (ed): Natural Immunity to Normal Hematopoietic Cells. Boca Raton, FL, CRC, 1994, p 33
24. Bancroft GJ, Sheehan KCF, Schreiber RD, Unanue ER: Tumor necrosis factor is involved in the T cell-independent pathway of macrophage activation in SCID mice. J Immunol 143:127, 1989
25. Schreiber RD, Hicks LJ, Celada A, Buchmeier NA, Gray PW: Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity. J Immunol 134:1609, 1985
26. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
27. Kagi D, Ledermann B, Burki K, Seiler P, Odermatt B, Olsen KJ, Podack ER, Zinkernagel RM, Hengartner H: Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31, 1994
28. Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S-I, Sameshima M, Hase A, Seto Y, Nagata S: The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233, 1991
29. Russell JH, Rush B, Weaver C, Wang R: Mature T cells of autoimmune lpr/lpr mice have a defect in antigen-stimulated suicide. Proc Natl Acad Sci USA 90:4409, 1993
30. Singer GG, Abbas AK: The Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1:365, 1994
31. + cytotoxic T cells. Proc Natl Acad Sci USA 91:4185, 1994
32. Hanabuchi S, Koyanagi M, Kawasaki A, Shinohara N, Matsuzawa A, Nishimura Y, Kobayashi Y, Yonehara S, Yagita H, Okumura K: Fas and its ligand in a general mechanism of T-cell mediated cytotoxicity. Proc Natl Acad Sci USA 91:4930, 1994
33. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 265:528, 1994
34. Lowin B, Hahne M, Mattmann C, Tschopp J: Cytolytic T-cell cytotoxicity is mediated through perforin and Fas pathways. Nature 370:650, 1994
35. Duke RC, Persechini PM, Chang S, Liu C-C, Cohen JJ, Young JD-E: Purified perforin induces target cell lysis but not DNA fragmentation. J Exp Med 160:75, 1989
36. Schulz M, Schuurma, H-J, Joergensen J, Steiner C, Meerloo T, Kagi D, Hengartner H, Zinkernagel RM, Schreier MH, Burki K, Ledermann B: Acute rejection of vascular heart allografts by perforin-deficient mice. Eur J Immunol 25:474, 1995
37. Selvaggi G, Inverardi L, Levy RB, Brendel MD, Spielman J, Kagi D, Hengartner H, Mintz DH, Podack E, Ricordi C: Tolerance without graft-versus-host disease in mice after allotransplantation of perforin-deficient bone marrow. J Clin Invest (in press)
38. Baker MB, Podack ER, Levy RB: Perform and Fas-mediated cytotoxic pathways are not required for allogeneic resistance to bone marrow grafts in mice. Biol Blood Marrow Transplant (in press)
39. 38a. Aguila HL, Weissman IL: Hematopoietic stem cells are not direct cytotoxic targets of natural killer cells. Blood 87:1225, 1996
40. + T cells. Proc Natl Acad Sci USA 92:10192, 1995